Bortezomib

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Bortezomib and local guidelines before prescribing.

Proteasome inhibitor

Mechanism

Proteasome inhibitor.

Uses

Multiple myeloma, mantle cell lymphoma.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Peripheral neuropathy, thrombocytopenia, diarrhoea, herpes zoster reactivation.

Interactions

CYP3A4 inhibitors and inducers.

Contraindications and cautions

Acute diffuse infiltrative lung disease

Monitoring

FBC, neuropathy

Pregnancy and breastfeeding

Avoid

Renal and hepatic impairment

Reduce dose in hepatic impairment

Overdose and reversal

Supportive

Special advice

Subcutaneous route reduces neuropathy; antiviral prophylaxis.

More from the textbook: uses, cautions and other points
Where it is discussed in the book